1990
DOI: 10.1016/0168-8278(90)90075-3
|View full text |Cite
|
Sign up to set email alerts
|

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
63
1
3

Year Published

1991
1991
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 215 publications
(70 citation statements)
references
References 23 publications
3
63
1
3
Order By: Relevance
“…Furthermore, a possible link to hepatocellular carcinoma has been proposed for HCV genotype 1b. There is compelling evidence that hepatocellular carcinoma occurs more frequently or emerges earlier among HCV-infected Japanese patients (125,137) than among HCV carriers in western countries (33,55). Because HCV genotype 1b is more common in Japan than in Europe or the United States, the hypothesis relating to genotype is attractive and appears to explain these differences.…”
Section: Progression Of Liver Diseasementioning
confidence: 98%
“…Furthermore, a possible link to hepatocellular carcinoma has been proposed for HCV genotype 1b. There is compelling evidence that hepatocellular carcinoma occurs more frequently or emerges earlier among HCV-infected Japanese patients (125,137) than among HCV carriers in western countries (33,55). Because HCV genotype 1b is more common in Japan than in Europe or the United States, the hypothesis relating to genotype is attractive and appears to explain these differences.…”
Section: Progression Of Liver Diseasementioning
confidence: 98%
“…Acute transfusion-associated non-A, non-B hepatitis (mainly hepatitis C) led to cirrhosis in 8% to 24%, hepatocellular carcinoma in 0% to 1.3%, and liver-related casualties in 1.6% to 6% of the cases within a mean follow-up of 8 to 14 years. [19][20][21][22][23] A prospective US national cohort study on transfusion-associated non-A, non-B and type C hepatitis with matched disease controls indicated a low risk of hepatitis-induced mortality (3%) after 18 years, 24 and in a 20-year update 40% chronicity, 15% cirrhosis, and only 26% recovery. 25 The risks may be underestimated because of the extremely high mortality (51%) caused by nonhepatic, mostly cardiac disease.…”
Section: Discussionmentioning
confidence: 99%
“…3 is the main causative agent for transfusion-associated and sporadic non-A, non-B hepatitis throughout the world (1). HCV often causes a prolonged and persistent infection (2) and plays an important role in the pathogenesis of virus-associated hepatocellular carcinoma (HCC) (3)(4)(5).…”
Section: Hepatitis C Virus (Hcv)mentioning
confidence: 99%